Iovance Biotherapeutics, Inc. v. Federal Insurance Company

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA IOVANCE BIOTHERAPEUTICS, INC., Case No. 25-cv-00040-RFL Plaintiff, REDACTED PUBLIC COPY v. ORDER RESOLVING MOTIONS FOR SUMMARY JUDGMENT FEDERAL INSURANCE COMPANY, Re: Dkt. Nos. 56, 81 Defendant. The parties do not dispute the following facts. Iovance develops cancer immunotherapy drugs. It partnered with five medical institutions to sponsor clinical trials. Clinical Trial Agreements (the “CTAs”) governed the relationships between Iovance and these institutions. The CTAs contain two provisions relevant to this action. - Eight…